PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in Finland
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.813
https://www.valueinhealthjournal.com/article/S1098-3015(12)02526-0/fulltext
Section Title :
Mental Health
Section Order :
322
First Page :
A337
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02526-0&doi=10.1016/j.jval.2012.08.813